[
  {
    "ts": "2026-01-05T09:11:00+00:00",
    "headline": "Rosacea Market Research and Forecast Report 2025-2035: Expansion Driven by Regulatory Approval of Novel Therapies Such as Emrosi and Rhofade and Rapid Adoption of Teledermatology Platforms",
    "summary": "Rosacea is a chronic skin condition that presents as facial redness, visible blood vessels, and acne-like bumps, affecting the face, neck, chest, and eyes. The global rosacea market is experiencing growth propelled by increasing cases in adults aged 30-60, expanded awareness, and newly approved treatments like Emrosi and Rhofade. Barriers such as high medication costs and underdiagnosis in darker skin tones remain. However, innovative therapies, the rise of teledermatology, and personalized skin",
    "url": "https://finance.yahoo.com/news/rosacea-market-research-forecast-report-091100203.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "02b5001e-f229-3115-8442-ff2f8eb34501",
      "content": {
        "id": "02b5001e-f229-3115-8442-ff2f8eb34501",
        "contentType": "STORY",
        "title": "Rosacea Market Research and Forecast Report 2025-2035: Expansion Driven by Regulatory Approval of Novel Therapies Such as Emrosi and Rhofade and Rapid Adoption of Teledermatology Platforms",
        "description": "",
        "summary": "Rosacea is a chronic skin condition that presents as facial redness, visible blood vessels, and acne-like bumps, affecting the face, neck, chest, and eyes. The global rosacea market is experiencing growth propelled by increasing cases in adults aged 30-60, expanded awareness, and newly approved treatments like Emrosi and Rhofade. Barriers such as high medication costs and underdiagnosis in darker skin tones remain. However, innovative therapies, the rise of teledermatology, and personalized skin",
        "pubDate": "2026-01-05T09:11:00Z",
        "displayTime": "2026-01-05T09:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rosacea-market-research-forecast-report-091100203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rosacea-market-research-forecast-report-091100203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "AbbVie (NYSE: ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.",
    "url": "https://finance.yahoo.com/news/abbvie-present-44th-annual-j-130000025.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "61e44537-03b6-3b54-b00b-9be229a97b12",
      "content": {
        "id": "61e44537-03b6-3b54-b00b-9be229a97b12",
        "contentType": "STORY",
        "title": "AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/fed558a259ce4691b403d42282ff5e52",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rPBBZQdv50AhJgNzpETkgg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fed558a259ce4691b403d42282ff5e52.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6fqQiBJYW_2AVoNHuToW8g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fed558a259ce4691b403d42282ff5e52.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-44th-annual-j-130000025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-44th-annual-j-130000025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-05T14:00:12+00:00",
    "headline": "AI took investors on a date in 2025. In 2026, analysts say it's time to foot the bill.",
    "summary": "As the AI trade becomes \"fractured,\" 2026 could see other stocks finally outshine the \"Magnificent Seven.\"",
    "url": "https://finance.yahoo.com/news/ai-took-investors-on-a-date-in-2025-in-2026-analysts-say-its-time-to-foot-the-bill-140012067.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "fdc0367e-61f0-4be9-a11f-fc4ab81ee26b",
      "content": {
        "id": "fdc0367e-61f0-4be9-a11f-fc4ab81ee26b",
        "contentType": "STORY",
        "title": "AI took investors on a date in 2025. In 2026, analysts say it's time to foot the bill.",
        "description": "",
        "summary": "As the AI trade becomes \"fractured,\" 2026 could see other stocks finally outshine the \"Magnificent Seven.\"",
        "pubDate": "2026-01-05T14:00:12Z",
        "displayTime": "2026-01-05T14:00:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/9e002280-e7f8-11f0-bfef-90c6396630ad",
          "originalWidth": 5027,
          "originalHeight": 3351,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dq9BdFxaViRaUssaVCGFvg--~B/aD0zMzUxO3c9NTAyNzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/9e002280-e7f8-11f0-bfef-90c6396630ad.cf.webp",
              "width": 5027,
              "height": 3351,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8dW1H1CZcAefrAvuCnzpKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/9e002280-e7f8-11f0-bfef-90c6396630ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ai-took-investors-on-a-date-in-2025-in-2026-analysts-say-its-time-to-foot-the-bill-140012067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ai-took-investors-on-a-date-in-2025-in-2026-analysts-say-its-time-to-foot-the-bill-140012067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MU"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "CVX"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "WM"
            },
            {
              "symbol": "HD"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "IREN"
            },
            {
              "symbol": "PANW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]